Biotech is Back to Work: JPM 2023 Week Wrap Up
LaVoie Health Science Blog
JANUARY 30, 2023
Here are the five key takeaways of the conference and what to expect as we come to the end the first month of the year: Biotech is Back: The COVID-19 pandemic caused a downturn for the biotech sector as whole, but JP Morgan Week showed a strong turnout, proving interest in both the science and investor sides of the industry.
Let's personalize your content